Latest News and Press Releases
Want to stay updated on the latest news?
-
AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!
-
Avricore Health announces audited year end results for 2024 and first quarter 2025, as well as it's plans for UK expansion.
-
New Canadian guideline for pediatric obesity care shifts focus from weight loss to improving health, mental wellbeing, and quality of life.
-
New Canadian guideline for pediatric obesity care shifts focus from weight loss to improving health, mental wellbeing, and quality of life.
-
AscellaHealth Highlights Rare Disease Capabilities and End-to-End Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025
-
AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates
-
Tec de Monterrey and UT Austin launch OriGen Health to advance precision medicine and Latino health using AI, genetics, and Latin America’s largest biobank
-
Optime Care has expanded partnership with Eton Pharmaceuticals to serve as the SP provider for GALZIN®, an FDA-approved treatment for Wilson Disease.
-
Alberta has become the first province in Canada to officially recognize obesity as a chronic disease.
-
AscellaHealth Commemorates Rare Disease Day, February 28, by Supporting Patients and Caregivers"